MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).


Journal

Oncology reports
ISSN: 1791-2431
Titre abrégé: Oncol Rep
Pays: Greece
ID NLM: 9422756

Informations de publication

Date de publication:
10 2020
Historique:
received: 20 03 2020
accepted: 24 06 2020
pubmed: 24 7 2020
medline: 29 10 2020
entrez: 24 7 2020
Statut: ppublish

Résumé

Epithelial‑mesenchymal transition (EMT), during which cancer cells lose the epithelial phenotype and gain the mesenchymal phenotype, has been verified to result in tumor migration and invasion. Numerous studies have shown that dysregulation of the Wnt/β‑catenin signaling pathway gives rise to EMT, which is characterized by nuclear translocation of β‑catenin and E‑cadherin suppression. Wnt/β‑catenin signaling was confirmed to be affected by microRNAs (miRNAs), several of which are down‑ or upregulated in metastatic cancer cells, indicating their complex roles in Wnt/β‑catenin signaling. In this review, we demonstrated the targets of various miRNAs in altering Wnt/β‑catenin signaling to promote or inhibit EMT, which may elucidate the underlying mechanism of EMT regulation by miRNAs and provide evidence for potential therapeutic targets in the treatment of invasive tumors.

Identifiants

pubmed: 32700744
doi: 10.3892/or.2020.7703
pmc: PMC7448411
doi:

Substances chimiques

CTNNB1 protein, human 0
MicroRNAs 0
Wnt Proteins 0
beta Catenin 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1299-1313

Références

Life Sci. 2017 Nov 1;188:163-171
pubmed: 28882645
Nature. 2000 Jul 6;406(6791):86-90
pubmed: 10894547
Mol Biol Rep. 2014 Dec;41(12):8163-7
pubmed: 25324171
Cell Mol Life Sci. 2020 Mar;77(5):919-935
pubmed: 31312879
Cell Death Dis. 2018 Jan 23;9(2):78
pubmed: 29362431
Mol Carcinog. 2018 Jul;57(7):842-853
pubmed: 29566281
Genes Dev. 2006 Aug 15;20(16):2202-7
pubmed: 16882971
World J Clin Oncol. 2014 Aug 10;5(3):311-22
pubmed: 25114847
Cancer Metastasis Rev. 2009 Jun;28(1-2):15-33
pubmed: 19169796
Development. 2003 Sep;130(18):4295-305
pubmed: 12900447
Nat Rev Drug Discov. 2010 Oct;9(10):775-89
pubmed: 20885409
Nat Med. 2011 Feb;17(2):211-5
pubmed: 21240262
Curr Cancer Drug Targets. 2013 Nov;13(9):935-44
pubmed: 24168189
Cancer Discov. 2015 Mar;5(3):264-73
pubmed: 25542447
Cancer Res. 2004 Apr 15;64(8):2734-9
pubmed: 15087387
Int J Mol Sci. 2019 Nov 07;20(22):
pubmed: 31703281
J Oncol. 2015;2015:865816
pubmed: 25883654
Nat Commun. 2013;4:2787
pubmed: 24225776
Int J Biochem Cell Biol. 2019 Jul;112:61-71
pubmed: 30959202
Curr Biol. 2000 Dec 14-28;10(24):1611-4
pubmed: 11137016
J Exp Clin Cancer Res. 2019 Feb 21;38(1):97
pubmed: 30791932
Nat Rev Cancer. 2007 Jun;7(6):415-28
pubmed: 17508028
Nat Rev Mol Cell Biol. 2001 Apr;2(4):285-93
pubmed: 11283726
Cancer Med. 2020 Apr;9(8):2686-2697
pubmed: 32077634
Cancer Lett. 2015 Sep 28;366(1):61-70
pubmed: 26070964
Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5332-5342
pubmed: 31298385
Int J Oncol. 2017 Nov;51(5):1563-1573
pubmed: 29048657
Acta Biochim Pol. 2012;59(4):467-74
pubmed: 23173124
Dev Cell. 2009 Jul;17(1):9-26
pubmed: 19619488
Oncogene. 2010 Jun 17;29(24):3490-500
pubmed: 20418909
Mol Cancer Res. 2015 Apr;13(4):681-8
pubmed: 25587085
Dev Biol. 2004 Sep 15;273(2):244-56
pubmed: 15328010
Exp Mol Med. 2018 Jan 19;50(1):e429
pubmed: 29350680
Nucleic Acids Res. 2014 Jan;42(1):609-21
pubmed: 24068553
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Oncotarget. 2015 Apr 20;6(11):9099-112
pubmed: 25868860
Cancer Lett. 2012 Aug 1;321(1):45-54
pubmed: 22429998
Am J Transl Res. 2017 Aug 15;9(8):3654-3664
pubmed: 28861156
Dev Biol. 2019 Apr 1;448(1):16-35
pubmed: 30721665
Mol Cancer Res. 2012 Oct;10(10):1319-31
pubmed: 22912335
PLoS One. 2010 Oct 04;5(10):
pubmed: 20957176
Cell Death Dis. 2019 May 8;10(5):372
pubmed: 31068580
World J Gastroenterol. 2018 Sep 28;24(36):4178-4185
pubmed: 30271082
Zhongguo Dang Dai Er Ke Za Zhi. 2015 Jul;17(7):757-62
pubmed: 26182289
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Mol Cancer. 2018 Aug 22;17(1):126
pubmed: 30134915
Mol Cell Biol. 2002 Sep;22(17):6100-10
pubmed: 12167704
Stem Cell Rev Rep. 2020 Jun;16(3):503-510
pubmed: 32125607
Cancer Med. 2018 Jan;7(1):146-156
pubmed: 29239144
Cancer Lett. 2015 Aug 1;364(1):33-43
pubmed: 25931210
Cell Death Dis. 2018 Aug 30;9(9):888
pubmed: 30166525
Oncol Rep. 2013 Apr;29(4):1579-87
pubmed: 23381389
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1193-8
pubmed: 19144919
Cell Signal. 2015 Mar;27(3):510-8
pubmed: 25578861
J Hematol Oncol. 2014 Mar 05;7:19
pubmed: 24598126
Mol Carcinog. 2015 Jun;54 Suppl 1:E148-61
pubmed: 25252218
Oncotarget. 2017 Jun 9;8(41):69538-69550
pubmed: 29050223
PLoS One. 2013 Nov 15;8(11):e79409
pubmed: 24260215
Mol Cell Biol. 2009 Nov;29(21):5923-40
pubmed: 19703993
Int J Oncol. 2012 Apr;40(4):1162-70
pubmed: 22211245
Anticancer Res. 2018 Apr;38(4):1937-1946
pubmed: 29599309
J Cell Sci. 2014 Jul 15;127(Pt 14):3116-30
pubmed: 24829151
J Cell Biochem. 2018 Feb;119(2):2124-2134
pubmed: 28857252
Nat Rev Mol Cell Biol. 2008 Aug;9(8):603-15
pubmed: 18648374
Clin Exp Pharmacol Physiol. 2019 Feb;46(2):144-152
pubmed: 30353914
Ann Oncol. 2014 Nov;25(11):2196-2204
pubmed: 25193986
J Pathol. 2013 Feb;229(3):379-89
pubmed: 22930392
Br J Cancer. 2016 Sep 6;115(6):731-40
pubmed: 27537390
Cancer Res Treat. 2019 Oct;51(4):1420-1429
pubmed: 30913872
Essays Biochem. 2013;54:29-38
pubmed: 23829525
BMC Cancer. 2017 Dec 22;17(1):886
pubmed: 29273006
Gynecol Oncol. 2009 Sep;114(3):457-64
pubmed: 19501389
Cell Physiol Biochem. 2015;35(1):71-82
pubmed: 25547151
Pharmacol Res. 2017 Sep;123:130-142
pubmed: 28712972
Int J Cancer. 2010 Jun 1;126(11):2575-83
pubmed: 19839049
Biomed Res Int. 2017;2017:6010926
pubmed: 28337453
Life Sci. 2019 Sep 15;233:116692
pubmed: 31351967
J Cell Biochem. 2018 Feb;119(2):2022-2035
pubmed: 28833449
Mol Cell Biol. 2006 Mar;26(6):2317-26
pubmed: 16508007
Biochem Biophys Res Commun. 2013 Sep 6;438(4):673-9
pubmed: 23939044
Gene. 2003 Jan 2;302(1-2):179-83
pubmed: 12527209
J Oncol. 2015;2015:792182
pubmed: 26425122
Biomed Pharmacother. 2018 Dec;108:492-499
pubmed: 30243081
Circ Res. 2010 Jun 25;106(12):1798-806
pubmed: 20576942
Pathol Oncol Res. 2019 Jan;25(1):377-389
pubmed: 29138985
Sci Rep. 2013;3:2687
pubmed: 24045437
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5
pubmed: 19666588
Int J Mol Med. 2016 Sep;38(3):776-84
pubmed: 27460529
Cancer Prev Res (Phila). 2018 Aug;11(8):503-510
pubmed: 29794245
Exp Cell Res. 2017 Nov 15;360(2):210-217
pubmed: 28890291
Gene. 2018 Nov 15;676:298-305
pubmed: 30144501
J Cell Mol Med. 2019 Sep;23(9):6295-6307
pubmed: 31273950
Cancer Invest. 2011 Jul;29(6):377-82
pubmed: 21649463
Oncotarget. 2016 Jul 5;7(27):42513-42526
pubmed: 27285761
Nat Rev Genet. 2010 Sep;11(9):597-610
pubmed: 20661255
Genes Dev. 2008 Apr 1;22(7):894-907
pubmed: 18381893
Cancer Sci. 2018 Feb;109(2):354-362
pubmed: 29160937
Gene. 2018 Oct 30;675:102-109
pubmed: 29960070
Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a002915
pubmed: 20182623
Eur Rev Med Pharmacol Sci. 2018 Mar;22(5):1290-1296
pubmed: 29565486
Metallomics. 2017 May 24;9(5):471-481
pubmed: 28205653
Dig Liver Dis. 2019 Sep;51(9):1314-1322
pubmed: 30948333
J Clin Invest. 2013 Feb;123(2):566-79
pubmed: 23321667
Sci Rep. 2017 Apr 20;7:44688
pubmed: 28425477
Pharmacol Res. 2016 Nov;113(Pt A):55-61
pubmed: 27498157
Mol Cell Biol. 2012 Nov;32(21):4388-99
pubmed: 22927647
J Cell Biochem. 2018 Nov 28;:
pubmed: 30485504
Oncol Res. 2016;24(4):271-7
pubmed: 27656838
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1265-1271
pubmed: 30942630
Clin Cancer Res. 2018 Sep 15;24(18):4612-4626
pubmed: 29691294
Tumour Biol. 2015 Dec;36(12):9395-403
pubmed: 26113407
J Exp Clin Cancer Res. 2019 Aug 16;38(1):358
pubmed: 31419987
J Clin Med. 2017 Dec 22;7(1):
pubmed: 29271928
Mol Cell Biol. 2010 Dec;30(24):5621-35
pubmed: 20937768
Cancer Genet. 2011 Sep;204(9):486-91
pubmed: 22018270
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37
pubmed: 30108335
Biosci Biotechnol Biochem. 2019 Jun;83(6):1062-1071
pubmed: 30950326
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a015081
pubmed: 23085770
Mol Med Rep. 2015 Apr;11(4):3108-14
pubmed: 25483817
Int J Oncol. 2015 Dec;47(6):2141-52
pubmed: 26459797
Cell. 2012 Jun 8;149(6):1192-205
pubmed: 22682243
Cancer. 2012 Jul 1;118(13):3365-76
pubmed: 22139708
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1002-1011
pubmed: 30779066
EMBO J. 2004 Oct 13;23(20):4051-60
pubmed: 15372072
Int J Cancer. 2011 Mar 15;128(6):1327-34
pubmed: 20473948
Int J Oncol. 2016 Jun;48(6):2236-46
pubmed: 27082441
Science. 2009 Nov 27;326(5957):1275-9
pubmed: 19965479
Mol Cells. 2018 May 31;41(5):423-435
pubmed: 29754471
Cancer Res. 2014 Jun 1;74(11):3031-42
pubmed: 24710410
Mol Ther. 2011 Jun;19(6):1116-22
pubmed: 21427705
Immune Netw. 2011 Jun;11(3):135-54
pubmed: 21860607
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
Nat Rev Genet. 2008 Feb;9(2):102-14
pubmed: 18197166
Exp Mol Pathol. 2019 Apr;107:23-31
pubmed: 30684462
Mol Cell Biol. 2006 Mar;26(6):2055-64
pubmed: 16507986
Front Cell Dev Biol. 2020 Mar 04;8:110
pubmed: 32195251
Cancer Lett. 2016 Jun 28;376(1):178-87
pubmed: 27037061
J Biol Chem. 2014 Dec 26;289(52):36101-15
pubmed: 25371200
Nature. 1999 Feb 25;397(6721):707-10
pubmed: 10067895
Onco Targets Ther. 2016 Apr 06;9:2035-47
pubmed: 27103830
Int J Mol Sci. 2019 Apr 25;20(8):
pubmed: 31027222
Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):197-207
pubmed: 29045811
Biochem J. 2017 Dec 14;474(24):4219-4251
pubmed: 29242381
Int J Mol Med. 2019 Apr;43(4):1817-1829
pubmed: 30816445
Mol Med Rep. 2019 Jul;20(1):151-161
pubmed: 31115507
Front Genet. 2012 Jul 02;3:120
pubmed: 22783274
Nat Cell Biol. 2008 May;10(5):593-601
pubmed: 18376396
Physiol Res. 2012;61(4):337-46
pubmed: 22670697
Wound Repair Regen. 2018 Jul;26(4):311-323
pubmed: 30118158
Curr Opin Cell Biol. 2014 Dec;31:56-66
pubmed: 25240174
Int J Biochem Mol Biol. 2012;3(2):117-36
pubmed: 22773954
Gut. 2016 Sep;65(9):1522-34
pubmed: 26941395
Stem Cells. 2009 Aug;27(8):1712-21
pubmed: 19544444
Cancer Res. 2010 Jun 1;70(11):4719-27
pubmed: 20484038
Cell Signal. 2019 Oct;62:109352
pubmed: 31260797
Cell Death Dis. 2018 Sep 20;9(10):960
pubmed: 30237499
Oncotarget. 2015 Nov 3;6(34):36231-44
pubmed: 26460549
Cancer Cell Int. 2018 May 9;18:72
pubmed: 29760585
Curr Opin Lipidol. 2017 Oct;28(5):387-396
pubmed: 28723729
Cell Physiol Biochem. 2018;51(1):470-486
pubmed: 30453289
PLoS One. 2016 Sep 13;11(9):e0162394
pubmed: 27622654
Cells. 2019 Oct 04;8(10):
pubmed: 31590237
Biosci Rep. 2019 Jun 28;39(6):
pubmed: 31171711
Eur Rev Med Pharmacol Sci. 2018 Nov;22(22):7750-7759
pubmed: 30536319
Oncol Res. 2018 Dec 27;27(1):9-17
pubmed: 29422112
Cell Mol Life Sci. 2016 Sep;73(18):3535-53
pubmed: 27151512
Oncol Rep. 2019 Mar;41(3):1638-1648
pubmed: 30592286
Cancer Biomark. 2020;28(3):351-363
pubmed: 32417760
Cancer Metastasis Rev. 2009 Jun;28(1-2):151-66
pubmed: 19153669
Mol Cancer Ther. 2009 May;8(5):1055-66
pubmed: 19435871
Biosci Rep. 2017 Sep 7;37(5):
pubmed: 28724603
Cornea. 2018 May;37(5):633-640
pubmed: 29384809
Oncol Rep. 2017 Jul;38(1):301-308
pubmed: 28586066
Cell Mol Biol Lett. 2017 Jul 17;22:12
pubmed: 28725241
J Cell Sci. 2003 Jul 1;116(Pt 13):2627-34
pubmed: 12775774
J Exp Clin Cancer Res. 2019 Feb 4;38(1):53
pubmed: 30717802
Eur J Cancer. 2015 Aug;51(12):1638-49
pubmed: 26025765
Genes Cells. 2006 Sep;11(9):1125-32
pubmed: 16923130
Nat Cell Biol. 2001 Jul;3(7):683-6
pubmed: 11433302
Mol Cancer Ther. 2012 Oct;11(10):2193-201
pubmed: 22821148
J Cell Physiol. 2020 Feb;235(2):1469-1479
pubmed: 31273789
Adv Sci (Weinh). 2019 Mar 07;6(9):1801885
pubmed: 31065520
Hum Reprod Update. 2010 Mar-Apr;16(2):142-65
pubmed: 19773286
Carcinogenesis. 2015 Nov;36(11):1363-71
pubmed: 26264654
J Biol Chem. 2018 May 4;293(18):6693-6706
pubmed: 29549123
Int J Mol Med. 2018 Jun;41(6):3147-3156
pubmed: 29512715
Mol Carcinog. 2014 Dec;53(12):960-9
pubmed: 23861222
Int J Oncol. 2012 Jan;40(1):71-9
pubmed: 21947321
Biomed Pharmacother. 2017 Dec;96:1216-1221
pubmed: 29239819
J Cell Mol Med. 2015 Dec;19(12):2832-41
pubmed: 26395974
Br J Cancer. 2015 Jan 6;112(1):131-9
pubmed: 25422915
J Cell Biochem. 2018 Jan;119(1):1027-1040
pubmed: 28685847
Oncogene. 2013 Mar 14;32(11):1351-62
pubmed: 22562246
Cell Death Differ. 2014 Dec;21(12):1900-13
pubmed: 25080937
Mol Biol Cell. 2016 Nov 1;27(21):3233-3244
pubmed: 27582386
Biomed Pharmacother. 2018 Oct;106:1370-1377
pubmed: 30119209
Cancer Biother Radiopharm. 2019 Sep;34(7):472-479
pubmed: 31135177

Auteurs

Yuhe Lei (Y)

Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Lei Chen (L)

Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Ge Zhang (G)

Department of Big Data Research of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong 510120, P.R. China.

Aiyun Shan (A)

Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Chunfeng Ye (C)

Department of Pediatrics, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

Bin Liang (B)

Formula Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

Jiayu Sun (J)

Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Xin Liao (X)

Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Changfeng Zhu (C)

Department of Pharmacy, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Yueyue Chen (Y)

Formula Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

Jing Wang (J)

Formula Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

Enxin Zhang (E)

Department of Oncology, Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong 518000, P.R. China.

Lijuan Deng (L)

Formula Pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH